F541-0019 Screening compound: N-{[3-(1,3-dimethyl-2-oxo-1,2-dihydroquinoxalin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}-2,2-diphenylacetamide

F541-0019 Screening compound: N-{[3-(1,3-dimethyl-2-oxo-1,2-dihydroquinoxalin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}-2,2-diphenylacetamide
F541-0019 Screening compound: N-{[3-(1,3-dimethyl-2-oxo-1,2-dihydroquinoxalin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}-2,2-diphenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F541-0019
N-{[3-(1,3-dimethyl-2-oxo-1,2-dihydroquinoxalin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}-2,2-diphenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F541-0019

Molecular Formula

C27H23N5O3 (C27 H23 N5 O3)

Compound Name

N-{[3-(1,3-dimethyl-2-oxo-1,2-dihydroquinoxalin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}-2,2-diphenylacetamide

IUPAC name

N-{[3-(13-dimethyl-2-oxo-12-dihydroquinoxalin-6-yl)-124-oxadiazol-5-yl]methyl}-22-diphenylacetamide

SMILES

CC1=Nc(cc(cc2)-c3noc(CNC(C(c4ccccc4)c4ccccc4)=O)n3)c2N(C)C1=O

InChI

InChI=1S/C27H23N5O3/c1-17-27(34)32(2)22-14-13-20(15-21(22)29-17)25-30-23(35-31-25)16-28-26(33)24(18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3-15,24H,16H2,1-2H3,(H,28,33)

InChI Key

LWDJUMOHNPBKHI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27174385

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

465.51

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.765

Distribution Coefficient, logD

3.765

Water Solubility, LogSw

-4.10

Polar Surface Area

78.145

Acid Dissociation Constant (pKa)

11.80

Base Dissociation Constant (pKb)

0.64

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

14.80

F541-0019 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F541-0019 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F541-0019?
Check Price and Availability of F541-0019, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F541-0019 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F541-0019
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F541-0019
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F541-0019 available by request